Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New glasses could help Kids' eyes stop getting worse

NCT ID NCT07465900

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested special glasses called C.A.R.E. lenses in 100 children aged 6-12 with nearsightedness. The lenses have rings that change how light hits the eye to slow down eye growth. After 12 months, researchers measured changes in eye length and prescription strength to see if the glasses work.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
C.A.R.E. spectacle lenses (special glasses with rings that change how light hits the eye)
What this could lead to
If it works, these glasses could help slow down worsening nearsightedness in children, reducing the need for stronger prescriptions.
What could go wrong
This is a small, early study with no comparison group, so results may not apply to all children. The lenses must be worn full-time, which some kids may find uncomfortable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Jan 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 6-12 years at enrollment. * Spherical equivalent refractive error between -0.75 and -6.00 diopters. * Astigmatism ≤1.50 diopters. * Best-corrected visual acuity of 0.1 logMAR or better. * Ability to comply with full-time spectacle wear. * Informed consent obtained from parent or legal guardian. Exclusion Criteria: * Amblyopia or strabismus. * Keratoconus or other corneal pathology. * Previous myopia control treatment (e.g., atropine therapy, orthokeratology). * History of ocular surgery. * Systemic disease affecting vision. * Poor compliance with spectacle wear.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia progression are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Benha University

    Banhā, Benha, 13111, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.